Association between life's crucial 9 and kidney stones: a population-based study.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-03-06 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1558628
Xiao-Ran Li, Han-Lin Liu, Li Wang, Jian-Wei Yang, Kang-Yu Wang, Si-Yu Chen, Li Yang
{"title":"Association between life's crucial 9 and kidney stones: a population-based study.","authors":"Xiao-Ran Li, Han-Lin Liu, Li Wang, Jian-Wei Yang, Kang-Yu Wang, Si-Yu Chen, Li Yang","doi":"10.3389/fmed.2025.1558628","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study examined the association between the Life's Crucial 9 (LC9) score and kidney stone prevalence in U.S. adults.</p><p><strong>Methods: </strong>Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2014, this cross-sectional analysis focused on adult participants with kidney stone onset or recurrence. LC9 scores were divided into four quartiles for analysis. Weighted multivariable logistic regression, restricted cubic spline (RCS) modeling, threshold effect analysis, and subgroup analyses were employed to evaluate the relationship between LC9 scores and kidney stone prevalence.</p><p><strong>Results: </strong>The study included 24,669 participants with an average age of 46.05 ± 0.34 years and a mean LC9 score of 73.76 ± 0.25. The overall prevalence of kidney stones was 8.45%, while the average recurrence rate stood at 2.96%. Importantly, for each one-point increase in the LC9 score, the incidence of kidney stones dropped by 1.2% (95% CI: 0.979 to 0.997, <i>p</i> = 0.014). Compared to the lowest quartile (Q1), the Q4 group exhibited a 0.305-fold higher recurrence rate (95% CI: 0.159 to 0.586, <i>p</i> < 0.001). Interaction analysis showed that race and gout significantly influenced the relationship between the LC9 score and kidney stone risk. Additionally, curve fitting and threshold effect analysis demonstrated a nonlinear association between LC9 scores and kidney stone recurrence, with a breakpoint identified at 72.777.</p><p><strong>Conclusion: </strong>An elevated LC9 score correlates with a lower risk of both kidney stone formation and recurrence. Maintaining an optimal LC9 score could be an effective approach for preventing kidney stones.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1558628"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11922861/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1558628","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study examined the association between the Life's Crucial 9 (LC9) score and kidney stone prevalence in U.S. adults.

Methods: Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2014, this cross-sectional analysis focused on adult participants with kidney stone onset or recurrence. LC9 scores were divided into four quartiles for analysis. Weighted multivariable logistic regression, restricted cubic spline (RCS) modeling, threshold effect analysis, and subgroup analyses were employed to evaluate the relationship between LC9 scores and kidney stone prevalence.

Results: The study included 24,669 participants with an average age of 46.05 ± 0.34 years and a mean LC9 score of 73.76 ± 0.25. The overall prevalence of kidney stones was 8.45%, while the average recurrence rate stood at 2.96%. Importantly, for each one-point increase in the LC9 score, the incidence of kidney stones dropped by 1.2% (95% CI: 0.979 to 0.997, p = 0.014). Compared to the lowest quartile (Q1), the Q4 group exhibited a 0.305-fold higher recurrence rate (95% CI: 0.159 to 0.586, p < 0.001). Interaction analysis showed that race and gout significantly influenced the relationship between the LC9 score and kidney stone risk. Additionally, curve fitting and threshold effect analysis demonstrated a nonlinear association between LC9 scores and kidney stone recurrence, with a breakpoint identified at 72.777.

Conclusion: An elevated LC9 score correlates with a lower risk of both kidney stone formation and recurrence. Maintaining an optimal LC9 score could be an effective approach for preventing kidney stones.

生活中至关重要的 9 个因素与肾结石之间的关系:一项基于人口的研究。
目的:本研究探讨了美国成年人的 "人生关键9分"(LC9)得分与肾结石患病率之间的关系:这项横断面分析使用了美国国家健康与营养调查(NHANES)2007 年至 2014 年的数据,重点研究了肾结石发病或复发的成年参与者。LC9得分被分为四个四分位数进行分析。研究采用了加权多变量逻辑回归、受限立方样条线(RCS)建模、阈值效应分析和亚组分析来评估 LC9 分数与肾结石患病率之间的关系:研究共纳入 24,669 名参与者,平均年龄为(46.05±0.34)岁,平均 LC9 得分为(73.76±0.25)分。肾结石的总体患病率为 8.45%,平均复发率为 2.96%。重要的是,LC9得分每增加1分,肾结石发病率就会下降1.2%(95% CI:0.979至0.997,p = 0.014)。与最低四分位数(Q1)相比,Q4 组的复发率高出 0.305 倍(95% CI:0.159 至 0.586,p 结论:LC9 评分升高与肾结石的发病率相关:LC9得分越高,肾结石形成和复发的风险越低。保持最佳的 LC9 评分是预防肾结石的有效方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信